Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
CC transcript
Asset disposition
|
|
Cyclacel Pharmaceuticals, Inc. (CYCC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/26/2023 |
SC 13G/A
| ACORN BIOVENTURES, L.P. reports a 10% stake in Cyclacel Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Ikarian Capital, LLC reports a 1% stake in Cyclacel Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| SPHERA FUNDS MANAGEMENT LTD. reports a 5.1% stake in Cyclacel Pharmaceuticals, Inc. |
| 02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| CVI Investments, Inc. reports a 4.9% stake in Cyclacel Pharmaceuticals, Inc. |
| 02/11/2021 |
SC 13G/A
| RENAISSANCE TECHNOLOGIES LLC reports a 0% stake in CYCLACEL PHARMACEUTICALS, INC. |
| 02/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/05/2020 |
SC 13G/A
| Eastern Capital LTD reports a 3.9% stake in Cyclacel Pharmaceuticals, Inc. |
| 08/25/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Eastern Capital LTD reports a 11% stake in Cyclacel Pharmaceuticals, Inc. |
| 02/12/2016 |
SC 13G/A
| Cyclacel Pharmaceuticals, Inc. reports a 0% stake in Cyclacel Pharmaceuticals, Inc. |
| 10/03/2013 |
SC 13G/A
| Redmile Group, LLC reports a 0% stake in Cyclacel Pharmaceuticals, Inc. |
| 11/09/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 08/09/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2011 |
SC 13G/A
| Cyclacel Pharmaceuticals, Inc. reports a 19.3% stake in Cyclacel Pharmaceuticals, Inc. |
| 02/11/2011 |
SC 13G/A
| Cyclacel Pharmaceuticals, Inc. reports a 2.5% stake in Cyclacel Pharmaceuticals, Inc. |
| 12/10/2010 |
SC 13G/A
| Cyclacel Pharmaceuticals, Inc. reports a 0% stake in CYCLACEL PHARMACEUTICALS INC |
| 12/02/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 10/12/2010 |
SC 13G/A
| Cyclacel Pharmaceuticals, Inc. reports a 4.3% stake in Cyclacel Pharmaceuticals, Inc. |
| 02/12/2010 |
SC 13G/A
| Cyclacel Pharmaceuticals, Inc. reports a 9.9% stake in CYCLACEL PHARMACEUTICALS INC |
| 09/10/2009 |
SC 13G/A
| Cyclacel Pharmaceuticals, Inc. reports a 4.3% stake in Cyclacel Pharmaceuticals, Inc. |
| 02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/12/2009 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 6.7% stake in Cyclacel Pharmaceuticals, Inc. |
|
|